| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.40B | 29.05B | 28.12B | 22.93B | 24.74B | 29.41B |
| Gross Profit | 6.11B | 5.77B | 5.38B | 4.04B | 3.45B | 4.93B |
| EBITDA | 2.36B | 2.02B | 1.31B | -53.20M | -424.38M | 711.99M |
| Net Income | 1.35B | 1.05B | 759.51M | -811.86M | -1.02B | 139.65M |
Balance Sheet | ||||||
| Total Assets | 22.74B | 23.65B | 23.88B | 21.63B | 21.87B | 22.50B |
| Cash, Cash Equivalents and Short-Term Investments | 3.88B | 3.88B | 2.88B | 2.12B | 3.55B | 3.02B |
| Total Debt | 4.96B | 5.53B | 6.58B | 7.15B | 6.78B | 4.01B |
| Total Liabilities | 13.75B | 14.76B | 15.89B | 15.05B | 14.46B | 14.05B |
| Stockholders Equity | 7.17B | 7.05B | 6.33B | 5.10B | 6.03B | 7.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.37B | 1.47B | -1.75B | -1.69B | -1.67B |
| Operating Cash Flow | 0.00 | 2.78B | 1.64B | -1.52B | -1.10B | -1.11B |
| Investing Cash Flow | 0.00 | -493.26M | -277.88M | -276.20M | -1.07B | -611.56M |
| Financing Cash Flow | 0.00 | -1.28B | -604.03M | 367.89M | 2.70B | 2.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.93B | 71.35 | ― | 4.43% | 0.63% | -24.87% | |
79 Outperform | ¥36.50B | 310.64 | ― | 2.26% | 20.13% | 33.43% | |
74 Outperform | ¥6.55B | 3.51 | ― | 0.53% | 4.93% | 23.92% | |
70 Outperform | ¥41.62B | 14.45 | ― | 2.93% | -0.90% | -13.24% | |
70 Outperform | ¥213.90B | 6.34 | 12.24% | 2.31% | -2.36% | -61.50% | |
68 Neutral | ¥27.51B | 9.33 | 14.95% | 0.77% | 6.43% | 368.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |